Discover the latest articles and news in related subjects. We also selected 187 mesenchymal tumors that were thought to mimic extraskeletal myxoid chondrosarcoma. These included 20 skeletal ...
June 25, 2007 — A novel marine-derived alkaloid called trabectedin has shown antitumor activity in patients with myxoid liposarcoma, according to a report published online June 21 in Lancet Oncology. ...
Extraskeletal myxoid chondrosarcoma is a rare mesenchymal soft-tissue malignancy of putative chondrocytic differentiation. Occasional overt cartilage formation, positivity for S-100 protein, and ...
Please provide your email address to receive an email when new articles are posted on . Nearly 40% of patients with advanced or metastatic synovial sarcoma or myxoid/round cell liposarcoma responded ...
Interim analysis of pivotal IGNYTE-ESO trial demonstrates 40% response rate in people with synovial sarcoma or myxoid/ round cell liposarcoma Company will lay out plans for its cell therapy sarcoma ...
The sea-squirt derived drug trabectedin (ecteinascidinin-743) shows anti-tumour activity in more than half of patients with a specific type of cancer, conclude an article in The Lancet Oncology. The ...
LENVAGIST - A multicenter, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib ...
Afamitresgene autoleucel (afami-cel) induced responses in a third of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma (MRCLS), according to results of the phase II SPEARHEAD-1 ...
A drug made from the sea squirt may help those with a form of cancer, a study in The Lancet Oncology suggests. Just over half of a study of 51 patients with a type of soft tissue sarcoma responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results